Synchrotron Imaging Informs Customized Cochlear Implant Programming
The maps the research team created using the synchrotron could make a huge difference to the sound quality of cochlear implants.
The maps the research team created using the synchrotron could make a huge difference to the sound quality of cochlear implants.
Envoy Medical has been awarded another patent which it has secured as part of its implantable hearing devices technology portfolio.
Clients may find it hard to make informed decisions about hearing care devices if they lack a comprehensive understanding of their options.
University Hospitals Cleveland Medical Center and UH Rainbow Babies and Children’s Hospital are participating in a Cochlear Americas’-sponsored clinical trial for an implantable hearing device in children 5 to 11 years of age who have been born with hearing loss that may be caused by craniofacial abnormalities.
Children born with severe hearing impairment underwent cochlear implant surgery, performed by a team of ENT's at Goa Hospital.
Envoy Medical Corporation, a hearing health company focused on providing innovative technologies across the hearing loss spectrum, announced an independent study that was published online in 'The Journal of Laryngology & Otology.' The study found that the fully implanted Esteem osseointegrated active middle ear implant (AMEI) showed “statistically significant improvements in post-operative hearing results,” according to Envoy.